OMI: Owens & Minor, Inc.
About
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.
Current Value
$12.411 Year Return
Current Value
$12.411 Year Return
Key Details
Market Cap
$956.92M
P/E Ratio
-19.4
1Y Stock Return
-33.32%
1Y Revenue Growth
4.22%
Dividend Yield
0.00%
Price to Book
1.1
Strategies that include OMI
Stock's related to OMI
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SPT | 49.84% | $1.67B | -46.02% | 0.00% |
| NVEC | 48.64% | $364.49M | +7.38% | 5.30% |
| KOP | 48.41% | $757.45M | -12.85% | 0.74% |
| CPS | 47.95% | $244.48M | -24.67% | 0.00% |
| TNC | 47.91% | $1.61B | -1.42% | 1.31% |
| UNIT | 45.88% | $1.38B | +4.61% | 8.01% |
| PINC | 45.32% | $2.14B | +5.54% | 3.79% |
| ASIX | 44.88% | $777.60M | +11.37% | 2.18% |
| JOUT | 44.72% | $328.98M | -37.36% | 4.09% |
| ASTE | 43.87% | $820.86M | +13.24% | 1.45% |
| TWI | 43.74% | $424.30M | -48.58% | 0.00% |
| OTEX | 41.18% | $7.59B | -26.30% | 3.55% |
| DKNG | 41.07% | $21.07B | +13.03% | 0.00% |
| MCFT | 40.59% | $344.65M | -0.29% | 0.00% |
| HFWA | 40.24% | $873.99M | +47.58% | 3.58% |
| TRC | 39.69% | $424.34M | -2.47% | 0.00% |
| QLYS | 39.65% | $5.18B | -21.75% | 0.00% |
| TRST | 39.61% | $691.41M | +34.26% | 3.98% |
| PARA | 39.50% | $6.89B | -26.53% | 1.94% |
| FIGS | 39.35% | $840.56M | -25.56% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PRPH | 0.05% | $18.14M | -82.61% | 0.00% |
| CRTO | 0.05% | $2.10B | +58.23% | 0.00% |
| TK | -0.07% | $728.26M | +11.06% | 0.00% |
| AVAL | -0.07% | $791.37M | -4.11% | 7.14% |
| IMNN | 0.12% | $10.02M | -22.89% | 0.00% |
| NIU | -0.13% | $126.87M | -28.79% | 0.00% |
| VIST | 0.14% | $4.75B | +67.10% | 0.00% |
| PG | -0.15% | $402.15B | +14.14% | 2.33% |
| TSN | 0.17% | $21.95B | +31.14% | 3.11% |
| RLMD | -0.24% | $89.92M | +1.36% | 0.00% |
| LQDA | -0.25% | $859.91M | +53.94% | 0.00% |
| FATBB | -0.28% | $81.94M | -12.91% | 11.69% |
| AMED | -0.34% | $2.95B | -3.95% | 0.00% |
| ALAR | -0.36% | $89.09M | +158.08% | 0.00% |
| SYRS | -0.38% | $7.43M | -90.46% | 0.00% |
| XOM | -0.40% | $521.39B | +13.56% | 3.22% |
| STNG | 0.44% | $2.96B | +0.87% | 2.75% |
| HUM | 0.45% | $33.45B | -45.22% | 1.25% |
| INSG | -0.52% | $157.28M | +540.25% | 0.00% |
| QUAD | -0.53% | $366.66M | +43.76% | 2.84% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HUSA | -19.45% | $16.69M | -11.56% | 0.00% |
| PCTY | -18.99% | $10.86B | +29.58% | 0.00% |
| CHD | -11.72% | $27.18B | +19.50% | 1.03% |
| SHEL | -11.28% | $205.19B | -1.07% | 4.20% |
| FOXF | -10.36% | $1.33B | -47.63% | 0.00% |
| LUNA | -9.60% | $55.69M | -71.48% | 0.00% |
| SRRK | -9.60% | $2.61B | +134.91% | 0.00% |
| VHC | -8.68% | $19.06M | -38.36% | 0.00% |
| CME | -8.51% | $82.76B | +9.21% | 1.98% |
| EQNR | -8.12% | $64.72B | -22.63% | 5.56% |
| MELI | -7.85% | $97.16B | +28.15% | 0.00% |
| TPST | -7.68% | $37.75M | -77.59% | 0.00% |
| STG | -7.34% | $35.67M | +7.92% | 0.00% |
| GAN | -7.02% | $83.39M | +21.19% | 0.00% |
| PPC | -6.97% | $12.38B | +100.96% | 0.00% |
| SMC | -6.92% | $383.35M | +97.26% | 0.00% |
| TTE | -6.89% | $138.45B | -11.95% | 5.50% |
| VSTA | -6.79% | $204.94M | -39.33% | 0.00% |
| CPSH | -5.93% | $20.70M | -40.13% | 0.00% |
| AMGN | -5.84% | $150.48B | +6.52% | 3.20% |
ETF's related to OMI
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TBIL | -0.01% | $4.38B | 0.15% |
| BCI | 0.02% | $1.20B | 0.26% |
| CLOI | 0.02% | $715.40M | 0.4% |
| BCD | -0.12% | $245.02M | 0.3% |
| FMF | -0.18% | $244.61M | 0.95% |
| DBMF | -0.79% | $1.02B | 0.85% |
| ULST | -0.93% | $535.47M | 0.2% |
| AGZD | 1.15% | $142.76M | 0.23% |
| SGOV | -1.15% | $27.53B | 0.09% |
| BILZ | 1.27% | $563.02M | 0.14% |
| GBIL | 1.42% | $5.60B | 0.12% |
| GCC | -1.45% | $133.23M | 0.55% |
| BSCO | 1.92% | $2.35B | 0.1% |
| KRBN | -2.12% | $242.47M | 0.85% |
| XHLF | 2.19% | $874.27M | 0.03% |
| CMDY | 2.45% | $279.14M | 0.28% |
| TPMN | 2.84% | $40.60M | 0.65% |
| CANE | 3.06% | $17.72M | 0.29% |
| CSHI | 3.15% | $482.85M | 0.38% |
| CORN | 3.71% | $61.12M | 0.2% |
News
SeekingAlpha
Henry Schein's acquisition could drive growth, but profitability worries linger. Read why HSIC stock is a cautious buy based on uncertain financial gains.
Yahoo
Owens & Minor (OMI) has disclosed a new risk, in the Corporate Activity and Growth category. Owens & Minor faces significant risks associated with the integration of Rotech following its acquisition, which may impact the realization of anticipated benefits. The challenges include potential operational disruptions, increased costs, and complexities in merging business practices and personnel. Management’s attention may be diverted to address these issues, potentially resulting in delays or perfor
Yahoo
Citi lowered the firm’s price target on Owens & Minor to $18.50 from $21 and keeps a Buy rating on the shares. The company’s Q3 results “were a bit of a mixed bag,” as revenue was largely in line while segment profitability was volatile, the analyst tells investors in a research note. The firm says Owens continues to work through its eligibility backlog due to the Change hack. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the
Yahoo
Owens & Minor ( (OMI) ) has shared an announcement. Owens & Minor reported a 5% rise in third-quarter revenue to $2.7 billion, driven by robust demand in Patient Direct and Medical Distribution. Despite a GAAP net loss of $13 million, adjusted earnings per share stood at $0.42. The company significantly reduced its debt by nearly $200 million, bolstering its financial position. Looking ahead, Owens & Minor anticipates sequential growth and improved cash flow, aiming for a revenue range of $10.6
Yahoo
Owens & Minor ( NYSE:OMI ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.72b (up 5.0% from 3Q 2023...
SeekingAlpha
Owens & Minor's diversified international presence and long-term agreements with clients ensure revenue stability and reduce volatility compared to smaller...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.